Viewing Study NCT06941857


Ignite Creation Date: 2025-12-24 @ 7:01 PM
Ignite Modification Date: 2025-12-28 @ 9:47 PM
Study NCT ID: NCT06941857
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: J2541
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View